Colorectal Cancer Clinical Trial
Official title:
Physsurg - a Controlled Randomized Trial on the Effect of Physical Activity in Relation to Outcome After Surgery
Verified date | November 2023 |
Source | Sahlgrenska University Hospital, Sweden |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will compare the outcome after surgery between a group of patients that receives instructions for prehabilitation training and one group that received standard treatment.
Status | Active, not recruiting |
Enrollment | 761 |
Est. completion date | December 31, 2025 |
Est. primary completion date | May 31, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Diagnosed colorectal cancer and a planned surgical procedure Exclusion Criteria: - HIPEC surgery, not able to give informed consent or understand the intervention |
Country | Name | City | State |
---|---|---|---|
Sweden | Sahlgrenska University Hospital/Östra | Göteborg | |
Sweden | Dept. of Surgery, Skaraborgs Sjukhus | Skövde |
Lead Sponsor | Collaborator |
---|---|
Sahlgrenska University Hospital, Sweden |
Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recovery measured as physical recovery measured in questionnaire | 4-6 weeks | ||
Secondary | Psychological recovery measured in a questionnaire, patient reported | Recovery | 4-6 weeks and 1 year post-operatively | |
Secondary | Recovery measured as time back to work | Recovery | 1 year | |
Secondary | Complications according to Clavien-Dindo | Postoperative complications | within 90 days | |
Secondary | QoL measured using SF-36 | QoL according to SF-36 | 4-6 weeks and 1 year | |
Secondary | QoL measured using EQ-5D | QoL according to EQ-5D | 4-6 weeks and 1 year | |
Secondary | QoL measured using a specifically developed instrument for this study | Health related QoL | 4-6 weeks and 1 year | |
Secondary | Mortality | Long term mortality | 3 and 5 years | |
Secondary | Re-admissions | Hospital re-admissions | 1 year | |
Secondary | Reoperations | Reoperations | 1 year | |
Secondary | Total time of hospital stay | Length of stay | 1 year | |
Secondary | IGF-1 and IGFBP-3 | Lab values | 4 weeks postopeartively | |
Secondary | Postoperative pain measured with Brief Pain Inventory-Short form | Pain measured by BPI-S | 4 weeks | |
Secondary | Postoperative pain measured with Brief Pain Inventory-Short form | Pain measured by BPI-S | 12 months | |
Secondary | Health economic analysis | Health economic analysis modified according to results of primary outcome | 4 weeks | |
Secondary | Health economic analysis | Health economic analysis modified according to results of primary outcome | 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |